Human Genome Sciences Inc. (HGSI) Reports Q1 EPS Loss of $0.69
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts HGSI Hot Sheet
Join SI Premium – FREE
Human Genome Sciences Inc. (NASDAQ: HGSI) reported Q1 EPS of ($0.69), $0.21 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $26.6 million versus the consensus estimate of $19.26 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADTRAN, Inc. (ADTN) Tops Q3 EPS by 5c; offers guidance
- Grab Holdings (GRAB) Misses Q3 EPS by 5c; raises guidance
- Archrock (AROC) Tops Q3 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
